Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in Vanda Pharmaceuticals Inc..

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Sell	3.9M	3.6M	-287K	€4.16–€4.78
2024-Q4	Sell	4M	3.9M	-158K	€4.06–€5.10
2024-Q3	Sell	4.1M	4M	-103K	€4.16–€5.80
2024-Q2	Sell	4.3M	4.1M	-162K	€3.76–€6.10
2024-Q1	Buy	3.7M	4.3M	+595K	€3.26–€4.24
2023-Q4	Buy	3.3M	3.7M	+415K	€3.04–€4.22
2023-Q3	Buy	3.1M	3.3M	+154K	€4.00–€6.00
2023-Q2	Buy	2.9M	3.1M	+177K	€5.45–€6.25
2023-Q1	Buy	2.9M	2.9M	+46K	€5.75–€7.10
2022-Q4	Sell	3.3M	2.9M	-406K	€6.35–€10.80
2022-Q3	Sell	3.6M	3.3M	-341K	€9.70–€11.57
2022-Q2	Buy	3.2M	3.6M	+428K	€8.90–€11.00
2022-Q1	Sell	3.2M	3.2M	-3.6K	€9.85–€14.40
2021-Q4	Sell	3.3M	3.2M	-70K	€13.80–€18.20
2021-Q3	Sell	3.3M	3.3M	-29K	€13.30–€17.80
2021-Q2	Sell	3.7M	3.3M	-376K	€12.80–€18.20
2021-Q1	Sell	4M	3.7M	-304K	€10.90–€15.70
2020-Q4	Sell	4.4M	4M	-391K	€8.20–€11.30
2020-Q3	Buy	4.2M	4.4M	+151K	€7.85–€10.50
2020-Q2	Buy	3.8M	4.2M	+380K	€9.05–€11.20
2020-Q1	Buy	3.5M	3.8M	+397K	€6.70–€15.10
2019-Q4	Buy	3.2M	3.5M	+245K	€11.20–€15.90
2019-Q3	Buy	2.8M	3.2M	+410K	€10.97–€14.17
2019-Q2	Buy	2.6M	2.8M	+233K	€11.87–€16.49
2019-Q1	Buy	2.5M	2.6M	+53K	€15.40–€27.14
2018-Q4	Buy	2M	2.5M	+463K	€16.57–€27.43
2018-Q3	Buy	1.6M	2M	+409K	€15.38–€19.43
2018-Q1	Buy	1.4M	1.6M	+205K	€11.30–€16.31
2017-Q4	Buy	1.2M	1.4M	+217K	€10.63–€15.13
2017-Q3	Buy	1.1M	1.2M	+120K	€12.63–€15.61
2017-Q2	Buy	939K	1.1M	+159K	€11.69–€14.22
2017-Q1	Buy	568K	939K	+371K	€11.84–€14.88
2016-Q4	Buy	432K	568K	+136K
2016-Q3	Buy	151K	432K	+281K
2016-Q2	Sell	417K	151K	-266K
2016-Q1	Buy	337K	417K	+80K
2015-Q4	Buy	195K	337K	+142K
2015-Q1	Sell	257K	195K	-62K
2013-Q3	Sell	354K	257K	-98K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors